Method for determining eligibility of brain tumor patient for tailor-made type peptide vaccine agent
AssigneeKurume University
InventorsKyogo ITO, Shigeki SHICHIJO
Life of this patent
Estimating the term…
Abstract
Provided are a method for determining whether a subject suffering from a brain tumor is an eligible person for a tailor-made peptide vaccine composition including at least one peptide antigen, a kit used in the aforesaid determination method, and a method for treating a subject suffering from a brain tumor by administering a tailor-made peptide vaccine composition including at least one peptide antigen.
Claims17
A method for determining whether a subject suffering from a brain tumor is an eligible person for a peptide vaccine composition including at least one peptide antigen, comprising:
- evaluating a risk of the subject with respect to the peptide vaccine composition to obtain an evaluation;
- and
- determining whether the subject is an eligible person for the peptide vaccine composition based on the evaluation to obtain a determination,
- wherein obtaining the evaluation comprises using at least one prognostic factor selected from the group consisting of GM-CSF, at least one SART2, MCP-1, VEGF, IL-6, IL-7, IL-10, IL-17, IL-1RA, CCL4, and haptoglobin.
A method for treating a subject suffering from a brain tumor by administering a peptide vaccine composition including at least one peptide antigen, wherein the subject is a person who is determined as an eligible person for the peptide vaccine composition based on an evaluation on a risk of the subject with regard to the peptide vaccine composition;
- and
- the evaluation is made based on at least one prognostic factor selected from the group consisting of GM-CSF, at least one SART2, MCP-1, VEGF, IL-6, IL-7, IL-10, IL-17, IL-1RA, CCL4, and haptoglobin.
Dependencies are inferred from the claim text.